マーケットレポート詳細
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
医療用サイクロトロンの世界市場規模は2022年で2億2130万ドル、2031年に3億630万億ドル、市場の平均年成長率は4.6%になる見込みです。
当レポートでは、医療用サイクロトロンの市場予測-2031年、各種セグメント別市場分析(製品別、用途別、国地域別、等)、市場ダイナミクス、COVID-19の影響分析、主要企業プロフィールなどの情報を盛り込み、概略以下の構成でお届けいたします。
【レポート構成概要】
・市場規模(US$)
サイクロトロン 10-12 MeV
サイクロトロン 16-24 MeV
サイクロトロン24MeV超
※(市場規模US$)
診断
・腫瘍学
・心臓病学
・神経学
研究
※(市場規模US$)
病院
診断センター
その他
※(市場規模US$)
北米
・米国、カナダ
欧州
・英国、ドイツ、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア/ニュージーランド
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
・GCC諸国、南アフリカ
・その他中東アフリカ
※地域別に各種セグメント別の細分化データ掲載、詳細は目次参照
市場ダイナミクス(促進要因、障壁、機会)
COVID-19の影響分析
競合状況
市場シェア分析
GE Healthcare
IBA Radiopharma Solutions
住友重機械工業株式会社
Advanced Cyclotron Systems
Siemens Healthineers AG
Best Cyclotron Systems, Inc.
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
4.1. Introduction
4.1.1. Market Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Medical Cyclotron Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5.1. Regulatory Scenario
5.2. Overview of types of cyclotrons currently on the market for various applications
5.3. Technological Advancements
5.4. Cyclotron and Radiopharmaceutical Facilities per region
5.5. COVID-19 Impact Analysis
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Cyclotron 10-12 MeV
6.3.2. Cyclotron 16-24 MeV
6.3.3. Cyclotron 24 MeV & above
6.4. Market Attractiveness Analysis, by Product
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Diagnosis
7.3.1.1. Oncology
7.3.1.2. Cardiology
7.3.1.3. Neurology
7.3.2. Research
7.4. Market Attractiveness Analysis, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2017–2031
8.3.1. Hospitals
8.3.2. Diagnostics Centers
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Product, 2017–2031
10.2.1. Cyclotron 10-12 MeV
10.2.2. Cyclotron 16-24 MeV
10.2.3. Cyclotron 24 MeV & above
10.3. Market Value Forecast, by Application, 2017–2031
10.3.1. Diagnosis
10.3.1.1. Oncology
10.3.1.2. Cardiology
10.3.1.3. Neurology
10.3.2. Research
10.4. Market Value Forecast, by End-user, 2017–2031
10.4.1. Hospitals
10.4.2. Diagnostics Centers
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Cyclotron 10-12 MeV
11.2.2. Cyclotron 16-24 MeV
11.2.3. Cyclotron 24 MeV & above
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Diagnosis
11.3.1.1. Oncology
11.3.1.2. Cardiology
11.3.1.3. Neurology
11.3.2. Research
11.4. Market Value Forecast, by End-user, 2017–2031
11.4.1. Hospitals
11.4.2. Diagnostics Centers
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
11.5.1. U.K.
11.5.2. Germany
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Cyclotron 10-12 MeV
12.2.2. Cyclotron 16-24 MeV
12.2.3. Cyclotron 24 MeV & above
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Diagnosis
12.3.1.1. Oncology
12.3.1.2. Cardiology
12.3.1.3. Neurology
12.3.2. Research
12.4. Market Value Forecast, by End-user, 2017–2031
12.4.1. Hospitals
12.4.2. Diagnostics Centers
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of APAC
12.6. Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Cyclotron 10-12 MeV
13.2.2. Cyclotron 16-24 MeV
13.2.3. Cyclotron 24 MeV & above
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Diagnosis
13.3.1.1. Oncology
13.3.1.2. Cardiology
13.3.1.3. Neurology
13.3.2. Research
13.4. Market Value Forecast, by End-user, 2017–2031
13.4.1. Hospitals
13.4.2. Diagnostics Centers
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Cyclotron 10-12 MeV
14.2.2. Cyclotron 16-24 MeV
14.2.3. Cyclotron 24 MeV & above
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Diagnosis
14.3.1.1. Oncology
14.3.1.2. Cardiology
14.3.1.3. Neurology
14.3.2. Research
14.4. Market Value Forecast, by End-user, 2017–2031
14.4.1. Hospitals
14.4.2. Diagnostics Centers
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. GE Healthcare
15.3.1.1. Company Overview
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. Business Strategies
15.3.1.5. Recent Developments
15.3.2. IBA Radiopharma Solutions
15.3.2.1. Company Overview
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. Business Strategies
15.3.2.5. Recent Developments
15.3.3. Sumitomo Heavy Industries, Ltd.
15.3.3.1. Company Overview
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. Business Strategies
15.3.3.5. Recent Developments
15.3.4. Advanced Cyclotron Systems
15.3.4.1. Company Overview
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. Business Strategies
15.3.4.5. Recent Developments
15.3.5. Siemens Healthineers AG
15.3.5.1. Company Overview
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. Business Strategies
15.3.5.5. Recent Developments
15.3.6. Best Cyclotron Systems, Inc.
15.3.6.1. Company Overview
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. Business Strategies
15.3.6.5. Recent Developments
Table 01: Global Medical Cyclotron Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 02: Global Medical Cyclotron Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 03: Global Medical Cyclotron Market Value (US$ Mn) Forecast, by Diagnosis, 2017–2031
Table 04: Global Medical Cyclotron Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 05: Global Medical Cyclotron Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America Medical Cyclotron Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 07: North America Medical Cyclotron Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 08: North America Medical Cyclotron Market Value (US$ Mn) Forecast, by Diagnosis, 2017–2031
Table 09: North America Medical Cyclotron Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 10: North America Medical Cyclotron Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 11: Europe Medical Cyclotron Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 12: Europe Medical Cyclotron Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 13: Europe Medical Cyclotron Market Value (US$ Mn) Forecast, by Diagnosis, 2017–2031
Table 14: Europe Medical Cyclotron Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 15: Europe Medical Cyclotron Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 16: Asia Pacific Medical Cyclotron Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 17: Asia Pacific Medical Cyclotron Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 18: Asia Pacific Medical Cyclotron Market Value (US$ Mn) Forecast, by Diagnosis, 2017–2031
Table 19: Asia Pacific Medical Cyclotron Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 20: Asia Pacific Medical Cyclotron Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 21: Latin America Medical Cyclotron Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 22: Latin America Medical Cyclotron Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 23: Latin America Medical Cyclotron Market Value (US$ Mn) Forecast, by Diagnosis, 2017–2031
Table 24: Latin America Medical Cyclotron Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 25: Latin America Medical Cyclotron Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 26: Middle East & Africa Medical Cyclotron Market Value (US$ Mn) Forecast, by Product, 2017–2031
Table 27: Middle East & Africa Medical Cyclotron Market Value (US$ Mn) Forecast, by Application, 2017–2031
Table 28: Middle East & Africa Medical Cyclotron Market Value (US$ Mn) Forecast, by Diagnosis, 2017–2031
Table 29: Middle East & Africa Medical Cyclotron Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 30: Middle East & Africa Medical Cyclotron Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Figure 01: Global Medical Cyclotron Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Medical Cyclotron Market Value Share Analysis, by Product, 2022 and 2031
Figure 03: Global Medical Cyclotron Market Value Share Analysis, by Cyclotron 10-12 MeV, 2022 and 2031
Figure 04: Global Medical Cyclotron Market Value Share Analysis, by Cyclotron 16-24 MeV, 2022 and 2031
Figure 05: Global Medical Cyclotron Market Value Share Analysis, by Cyclotron 24 MeV above, 2022 and 2031
Figure 06: Global Medical Cyclotron Market Attractiveness Analysis, by Product, 2023–2031
Figure 07: Global Medical Cyclotron Market Value Share Analysis, by Application, 2022 and 2031
Figure 08: Global Medical Cyclotron Market Value Share Analysis, by Diagnosis, 2022 and 2031
Figure 09: Global Medical Cyclotron Market Value Share Analysis, by Research, 2022 and 2031
Figure 10: Global Medical Cyclotron Market Attractiveness Analysis, by Application, 2023–2031
Figure 11: Global Medical Cyclotron Market Value Share Analysis, by End-user, 2022 and 2031
Figure 12: Global Medical Cyclotron Market Value Share Analysis, by Hospitals, 2022 and 2031
Figure 13: Global Medical Cyclotron Market Value Share Analysis, by Diagnostic Centers, 2022 and 2031
Figure 14: Global Medical Cyclotron Market Value Share Analysis, by Others, 2022 and 2031
Figure 15: Global Medical Cyclotron Market Attractiveness Analysis, by End-user, 2023–2031
Figure 16: Global Medical Cyclotron Market Value Share Analysis, by Region, 2022 and 2031
Figure 17: Global Medical Cyclotron Market Attractiveness Analysis, by Region, 2023–2031
Figure 18: North America Medical Cyclotron Market Value (US$ Mn) Forecast, 2017–2031
Figure 19: North America Medical Cyclotron Market Value Share Analysis, by Product, 2022 and 2031
Figure 20: North America Medical Cyclotron Market Attractiveness Analysis, by Product, 2023–2031
Figure 21: North America Medical Cyclotron Market Value Share Analysis, by Application, 2022 and 2031
Figure 22: North America Medical Cyclotron Market Attractiveness Analysis, by Application, 2023–2031
Figure 23: North America Medical Cyclotron Market Value Share Analysis, by End-user, 2022 and 2031
Figure 24: North America Medical Cyclotron Market Attractiveness Analysis, by End-user, 2023–2031
Figure 25: North America Medical Cyclotron Market Value Share Analysis, by Country, 2022 and 2031
Figure 26: North America Medical Cyclotron Market Attractiveness Analysis, by Country, 2023–2031
Figure 27: Europe Medical Cyclotron Market Value (US$ Mn) Forecast, 2017–2031
Figure 28: Europe Medical Cyclotron Market Value Share Analysis, by Product, 2022 and 2031
Figure 29: Europe Medical Cyclotron Market Attractiveness Analysis, by Product, 2023–2031
Figure 30: Europe Medical Cyclotron Market Value Share Analysis, by Application, 2022 and 2031
Figure 31: Europe Medical Cyclotron Market Attractiveness Analysis, by Application, 2023–2031
Figure 32: Europe Medical Cyclotron Market Value Share Analysis, by End-user, 2022 and 2031
Figure 33: Europe Medical Cyclotron Market Attractiveness Analysis, by End-user, 2023–2031
Figure 34: Europe Medical Cyclotron Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 35: Europe Medical Cyclotron Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 36: Asia Pacific Medical Cyclotron Market Value (US$ Mn) Forecast, 2017–2031
Figure 37: Asia Pacific Medical Cyclotron Market Value Share Analysis, by Product, 2022 and 2031
Figure 38: Asia Pacific Medical Cyclotron Market Attractiveness Analysis, by Product, 2023–2031
Figure 39: Asia Pacific Medical Cyclotron Market Value Share Analysis, by Application 2022 and 2031
Figure 40: Asia Pacific Medical Cyclotron Market Attractiveness Analysis, by Application, 2023–2031
Figure 41: Asia Pacific Medical Cyclotron Market Value Share Analysis, by End-user, 2022 and 2031
Figure 42: Asia Pacific Medical Cyclotron Market Attractiveness Analysis, by End-user, 2023–2031
Figure 43: Asia Pacific Medical Cyclotron Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 44: Asia Pacific Medical Cyclotron Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 45: Latin America Medical Cyclotron Market Value (US$ Mn) Forecast, 2017–2031
Figure 46: Latin America Medical Cyclotron Market Value Share Analysis, by Product, 2022 and 2031
Figure 47: Latin America Medical Cyclotron Market Attractiveness Analysis, by Product, 2023–2031
Figure 48: Latin America Medical Cyclotron Market Value Share Analysis, by Application, 2022 and 2031
Figure 49: Latin America Medical Cyclotron Market Attractiveness Analysis, by Application, 2023–2031
Figure 50: Latin America Medical Cyclotron Market Value Share Analysis, by End-user, 2022 and 2031
Figure 51: Latin America Medical Cyclotron Market Attractiveness Analysis, by End-user, 2023–2031
Figure 52: Latin America Medical Cyclotron Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 53: Latin America Medical Cyclotron Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 54: Middle East & Africa Medical Cyclotron Market Value (US$ Mn) Forecast, 2017–2031
Figure 55: Middle East & Africa Medical Cyclotron Market Value Share Analysis, by Product, 2022 and 2031
Figure 56: Middle East & Africa Medical Cyclotron Market Attractiveness Analysis, by Product, 2023–2031
Figure 57: Middle East & Africa Medical Cyclotron Market Value Share Analysis, by Application, 2022 and 2031
Figure 58: Middle East & Africa Medical Cyclotron Market Attractiveness Analysis, by Application, 2023–2031
Figure 59: Middle East & Africa Medical Cyclotron Market Value Share Analysis, by End-user, 2022 and 2031
Figure 60: Middle East & Africa Medical Cyclotron Market Attractiveness Analysis, by End-user, 2023–2031
Figure 61: Middle East & Africa Medical Cyclotron Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 62: Middle East & Africa Medical Cyclotron Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 63: Global Medical Cyclotron Market Share Analysis, by Company, 2022